|
|
| Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help |
|
Health Affairs, 25, no. 5 (2006):
1319-1331
doi: 10.1377/hlthaff.25.5.1319 © 2006 by Project HOPE |
|
 |
|||||||||||||
| ||||||||||||||||||||
Benefit Design And Specialty Drug Use
Goldman
et al.
Health Affairs
25, no. 5 (2006): 1319
Online Technical Appendix
This Data Supplement consists of supplemental material that, because of space constraints, was not included with the published paper by Dana P. Goldman and colleagues, "Benefit Design and Specialty Drug Use."
DISCLAIMER: This material is presented to supplement the published paper. Although it was part of the manuscript that was subjected to the scrutiny of external reviewers, it has not been edited or formatted by the editors of Health Affairs; the authors are solely responsible for any errors herein.
Files in this Data Supplement:
| Home | | | Current Issue | | | Archives | | | Topic Collections | | | Search | | | Blog | | | Subscribe | | | Contact Us | | | Help |
|
© 2001-2009 Project
HOPE–The People-to-People Organization |
||||||||||||||||